Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.02
Delayed Data
As of May 25
 +0.05 / +5.15%
Today’s Change
0.64
Today|||52-Week Range
2.10
-27.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization--2.0K999.572.0K
 
 
 
 
 
Operating ExpensesGross Income0.00-2.0K-999.57-2.0K
 
 
 
 
General Expenses348.6K472.0K394.8K743.9K
 
 
 
 
 
Other Operating Expenses0.00-0.000.000.00
 
 
Research And Development38.9K68.0K133.9K333.9K
 
 
 
 
 
Total Operating Expenses348.6K474.0K395.8K745.9K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-348.6K-474.0K-395.8K-745.9K
 
 
 
 
 
Extraordinary Charge0.00--0.00-1.6M
 
 
Other Expenses-222.5K53.2K-47.0K212.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-571.1K-420.8K-442.8K-2.1M
 
 
 
 
 
Minority Interest-1.9K0.000.000.00
 
 
Discontinued Operations-426.4K0.000.00-229.6K
 
 
 
Net Income-999.4K-420.8K-442.8K-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.7M13.7M13.7M13.7M
 
 
 
 
 
Shares To Calculate EPS Diluted11.7M13.7M13.7M13.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.02-$0.04--
 
 
 
 
EPS Diluted-$0.09-$0.04-$0.04-$0.18